Molecular Docking and Antimalarial Evaluation of Natural Phenolics and Their Derivatives on Plasmodium falciparum Lactate Dehydrogenase as Schizonticidal Drug Candidates
Barre latérale de l'article
Contenu principal de l'article
Résumé
Background: Antimalarial drug resistance is increasing in Sub-Saharan Africa. Natural phenolic compounds are known to have antimalarial activity and should be harnessed to reduce the malaria burden. A potential mechanism of schizonticidal action is the inhibition of Plasmodium falciparum lactate dehydrogenase. This study aimed to evaluate the binding affinity of natural phenolics and their derivatives on Plasmodium falciparum lactate dehydrogenase.
Methods: 35 compounds were downloaded from the Protein Data Bank and their binding energy on Plasmodium falciparum lactate dehydrogenase was evaluated using Autodock tools. Derivatives of compounds with the best binding energy and pharmacokinetic parameters were designed using ChemSketch and their binding energy was obtained. The protein-ligand interaction was analyzed using Discovery Studio.
Results: Curcumin had binding energy of -6.95kcal/mol, vitexin had binding energy of -7.44kcal/mol and daidzein had binding energy of -7kcal/mol. Two derivatives of curcumin had binding energy of -7.61kcal/mol, and -7.24kcal/mol. Two derivatives of vitexin had binding energy of -8.02kcal/mol and -7.48kcal/mol. These compounds had favorable biological and pharmacokinetic properties and possessed binding energy better than reference compounds; dihydroartemisinin(-6.8kcal/mol), quinine(-7.2kcal/mol), and chloroquine(-5.76kcal/mol).
Conclusion: Derivatized compounds had antiplasmodial potential and in vitro, in vivo work should be done to ascertain their schizonticidal activity.
Téléchargements
Renseignements sur l'article
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
Meibalan E, Marti M. Biology of Malaria Transmission. Cold Spring Harbor Perspectives in Medicine 2017;7:a025452. https://doi.org/10.1101/CSHPERSPECT.A025452
Garrido-Cardenas, J.A., González-Cerón, L., Manzano-Agugliaro, F. et al. Plasmodium genomics: an approach for learning about and ending human malaria. Parasitol Res 118, 1–27 (2019). https://doi.org/10.1007/s00436-018-6127-9
Okorie PN, Popoola KO, Awobifa OM, Ibrahim KT, Ademowo GO. Species composition and temporal distribution of mosquito populations in Ibadan, Southwestern Nigeria. J Entomol Zool Stud. 2014 Aug;2(4):164-169. PMID: 25520960; PMCID: PMC4266488
Foley M, Tilley L. Quinoline antimalarials: Mechanisms of action and resistance. International Journal for Parasitology 1997;27:231–40. https://doi.org/10.1016/S0020-7519(96)00152-X
Yang J, He Y, Li Y, Zhang X, Wong YK, Shen S, et al. Advances in the research on the targets of anti-malaria actions of artemisinin. Pharmacology & Therapeutics 2020;216:107697. https://doi.org/10.1016/J.PHARMTHERA.2020.107697
Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, et al. Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003–2015. The American Journal of Tropical Medicine and Hygiene 2018;98:692–9. https://doi.org/10.4269/ajtmh.17-0763
Marchetti R v., Lehane AM, Shafik SH, Winterberg M, Martin RE, Kirk K. A lactate and formate transporter in the intraerythrocytic malaria parasite, Plasmodium falciparum. Nat Commun 2015;6. https://doi.org/10.1038/NCOMMS7721
Elliott JL, Saliba KJ, Kirk K. Transport of lactate and pyruvate in the intraerythrocytic malaria parasite, Plasmodium falciparum. Biochem J 2001;355:733–9. https://doi.org/10.1042/BJ3550733
Possemiers H, Vandermosten L, van den Steen PE. Etiology of lactic acidosis in malaria. PLoS Pathog 2021;17. https://doi.org/10.1371/JOURNAL.PPAT.1009122
Oyelade J, Isewon I, Rotimi S, Okunoren I. Modeling of the Glycolysis Pathway in Plasmodium falciparum using Petri Nets. Bioinform Biol Insights 2016;10:49–57. https://doi.org/10.4137/BBI.S37296
Granchi C, Bertini S, Macchia M, Minutolo F. Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials. Current Medicinal Chemistry 2010;17:672–97. https://doi.org/10.2174/092986710790416263
Mamede L, Ledoux A, Jansen O, Frédérich M. Natural Phenolic Compounds and Derivatives as Potential Antimalarial Agents. Planta Medica 2020;86:585–618. https://doi.org/10.1055/A-1148-9000
Martí Coma-Cros E, Biosca A, Lantero E, Letizia Manca M, Caddeo C, Gutiérrez L, et al. Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit ®-Containing Liposomes. Int J Mol Sci. 2018 May 4;19(5):1361. doi: 10.3390/ijms19051361 https://doi.org/10.3390/ijms19051361
Dohutia C, Chetia D, Gogoi K, Bhattacharyya DR, Sarma K. Molecular docking, synthesis and in vitro antimalarial evaluation of certain novel curcumin analogs. Brazilian Journal of Pharmaceutical Sciences 2018;53:84. https://doi.org/10.1590/S2175-97902017000400084